Baxδ2 promotes apoptosis through caspase-8 activation in microsatellite-unstable colon cancer

Molecular Cancer Research

Volumn 12, Issue 9, 2014, Pages 1225-1232

  Zhang, Honghong ^a   Lin, Yuting ^a   Mañas, Adriana ^a   Zhao, Yu ^a   Denning, Mitchell F ^c   Ma, Li ^b   Xiang, Jialing ^a  

^a Illinois Institute of Technology   (United States)

^b ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 8; CISPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; INDOMETACIN; IRINOTECAN; PACLITAXEL; PROTEIN BAX; VINBLASTINE; CASPASE 3; ISOPROTEIN;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL INVASION ASSAY; COLON CANCER; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; COLORECTAL NEOPLASMS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROSATELLITE INSTABILITY; PATHOLOGY;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSATELLITE INSTABILITY; PROTEIN ISOFORMS;

EID: 84907274821     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0162     Document Type: Article

References (50)

1. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-63.
2. Sia EA, Jinks-Robertson S, Petes TD. Genetic control of microsatellite stability. Mutat Res 1997;383:61-70.
3. Perucho M. Cancer of the microsatellite mutator phenotype. BiolChem 1996;377:675-84.
4. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
5. Elliott B, Jasin M. Repair of double-strand breaks by homologous recombination in mismatch repair-defectivemammalian cells. Mol Cell Biol 2001;21:2671-82.
6. Lynch HT, Lynch PM. The cancer-family syndrome: a pragmatic basis for syndrome identification. Dis Colon Rectum 1979;22:106-10.
7. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64: 430-3.
8. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, et al. Cancer risk in mutation carriers of DNA-mismatch- repair genes. Int J Cancer 1999;81:214-8.
9. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
10. Abdel-Rahman WM, Ollikainen M, Kariola R, Jarvinen HJ, Mecklin JP, Nystrom-Lahti M, et al. Comprehensive characterization of HNPCCrelated colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 2005;24:1542-51.
11. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002;62:2447-54.
12. Yamaguchi T, Iijima T, Mori T, Takahashi K, Matsumoto H, Miyamoto H, et al. Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 2006;49:399-406.
13. Ham MF, Takakuwa T, Luo WJ, Liu A, Horii A, Aozasa K. Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability. Cancer Sci 2006;97:226-34.
14. Miquel C, Jacob S, Grandjouan S, Aime A, Viguier J, Sabourin JC, et al. Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability. Oncogene 2007;26:5919-26.
15. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase- 5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999; 59:2995-3002.
16. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275: 967-9.
17. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290: 989-92.
18. Olejniczak SH, Hernandez-Ilizaliturri FJ, Clements JL, Czuczman MS. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression. Clin Cancer Res 2008;14:1550-60.
19. Jeong SH, Lee HW, Han JH, Kang SY, Choi JH, Jung YM, et al. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. Jpn J Clin Oncol 2008;38:661-9.
20. Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 1999;59:1693s-1700s.
21. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
22. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL- 2 family reunion. Mol Cell 2010;37:299-310.
23. Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 2006;1757:1301-11.
24. Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K, et al. Regulated targeting of BAX to mitochondria. J Cell Biol 1998;143: 207-15.
25. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A 1998;95:4997-5002.
26. Zhou M, Demo SD, McClure TN, Crea R, Bitler CM. A novel splice variant of the cell death-promoting protein BAX. J Biol Chem 1998;273:11930-6.
27. Thomas AL, Price C, Martin SG, Carmichael J, Murray JC. Identification of two novel mRNA splice variants of bax. Cell Death Differ 1999;6: 97-8.
28. Schmitt E, Paquet C, Beauchemin M, Dever-Bertrand J, Bertrand R. Characterization of Bax-sigma, a cell death-inducing isoform of Bax. Biochem Biophys Res Commun 2000;270:868-79.
29. Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT, Jezequel P, et al. The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet 2002;11:675-87.
30. Fu NY, Sukumaran SK, Kerk SY, Yu VC. Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism. Mol Cell 2009;33:15-29.
31. Wang K, Gross A, Waksman G, Korsmeyer SJ. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol Cell Biol 1998;18:6083-9.
32. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002;2:183-92.
33. Cartron PF, Priault M, Oliver L, Meflah K, Manon S, Vallette FM. The Nterminal end of Bax contains a mitochondrial-targeting signal. J Biol Chem 2003;278:11633-41.
34. Shi B, Triebe D, Kajiji S, Iwata KK, Bruskin A, Mahajna J. Identification and characterization of baxepsilon, a novel bax variant missing the BH2 and the transmembrane domains. Biochem Biophys Res Commun 1999;254:779-85.
35. Shima K, Morikawa T, Yamauchi M, Kuchiba A, Imamura Y, Liao X, et al. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers. PLoS ONE 2011;6:e25062.
36. Haferkamp B, Zhang H, Lin Y, Yeap X, Bunce A, Sharpe J, et al. BaxDelta2 is a novel bax isoform unique to microsatellite unstable tumors. J Biol Chem 2012;287:34722-9.
37. Haferkamp B, Zhang H, Kissinger S, Wang X, Lin Y, Schultz M, et al. BaxDelta2 family alternative splicing salvages Bax microsatelliteframeshift mutations. Genes Cancer 2013;4:501-12.
38. Sitailo LA, Tibudan SS, Denning MF. Activation of caspase-9 is required for UV-induced apoptosis of human keratinocytes. J Biol Chem 2002;277:19346-52.
39. Puck TT, Marcus PI. Action of x-rays on mammalian cells. J Exp Med 1956;103:653-66.
40. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 2006;13:1423-33.
41. Chang DW, Xing Z, Capacio VL, Peter ME, Yang X. Interdimer processing mechanism of procaspase-8 activation. EMBO J 2003;22: 4132-42.
42. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999;274:1156-63.
43. Kantari C, Walczak H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta 2011;1813: 558-63.
44. Denning MF, Wang Y, Tibudan S, Alkan S, Nickoloff BJ, Qin JZ. Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ 2002;9:40-52.
45. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009;137:721-35.
46. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995;270:96-9.
47. Miquel C, Borrini F, Grandjouan S, Auperin A, Viguier J, Velasco V, et al. Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability. Am J Clin Pathol 2005;123:562-70.
48. Molenaar JJ, Gerard B, Chambon-Pautas C, Cave H, Duval M, Vilmer E, et al. Microsatellite instability and frameshift mutations in BAX and transforming growth factor-beta RII genes are veryuncommon in acute lymphoblastic leukemia in vivo but not in cell lines. Blood 1998;92: 230-3.
49. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-32.
50. Reed JC. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 2006;13:1378-86.